Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition characterized by rapid onset of widespread inflammation in the lungs, leading to significant breathing difficulties.
InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...
HMPV virus is not a novel virus - It was first isolated in 2001 by Van den Hoogen and her colleagues in Netherlands in the ...
Pharmaceutical Technology on MSN11d
InflaRx wins EU approval for Gohibic in Covid-19-induced ARDSThe European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...
Alzheimer's disease Therapeutics Market. LAS VEGAS, NV, UNITED STATES, January 23, 2025 /EINPresswire / -- DelveInsight's“Acute Respiratory Distress Synd ...
The use of electromagnetic navigation bronchoscopy (ENB)-guided microwave ablation (MWA) is safe and efficacy in treating patients with multiple bilateral pulmonary ground-glass opacities (GGOs). • ...
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...
Mechanical ventilation (MV) is a critical intervention for patients suffering from Acute Respiratory Distress Syndrome (ARDS), a severe condition characterized by widespread inflammation in the lungs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback